Abstract CT025: Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG)
Vivek Subbiah, Alexander Stein, Martin J. van den Bent, Antje Wick, Filip De Vos, Nikolas von Bubnoff, Myra E. van Linde, Albert Lai, Gerald W. Prager, Mario Campone, Angelica Fasolo, José A. López-Martín, Tae Min Kim, Ralf‐Dieter Hofheinz, Jean Yves Blay, Daniel C. Cho, Anas Gazzah, Damien Pouessel, Jeffrey Yachnin, Aislyn Boran, Paul Burgess, Palanichamy Ilankumaran, Eduard Gasal, Patrick Y. Wen (2021). Abstract CT025: Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG). , 81(13_Supplement), DOI: https://doi.org/10.1158/1538-7445.am2021-ct025.
